- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
M
MESO
Mesoblast
17.87
0.68+3.96%After Hours: 17.88 +0.01 +0.06%18:47 12/05 EST
OPEN/PREV CLOSE17.56/17.19
TODAY RANGE17.56-18.15
VOL247.88K
MARKET CAP2.29B
52 WEEK RANGE9.61-22.00
AVG VOL (3M)235.43K
% TURNOVER0.19%
TURNOVER--
P/E (TTM)-21.1304
% RANGE3.45%
EPS(TTM)-0.8457
P/E(FORWARD)-74.4583
P/B3.828
BVPS4.668
DIVIDEND--
P/S132.96
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.18B
SHARES OUTSTANDING128.29M
NEXT EARNINGS02/25-03/02
FREE FLOAT121.76M
LOT SIZE1
EX-DATE01/10/2024
News
Press Releases
Financial Reports
Profile
Reuters·4d ago
MESOBLAST PARTICIPATION AT PIPER SANDLER CONFERENCE
Benzinga·11/26 16:30
Urban Outfitters, Arrowhead Pharmaceuticals, Petco Health and Wellness And Other Big Stocks Moving Higher On Wednesday
TipRanks·11/26 11:33
Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025
Benzinga·11/26 09:33
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
TipRanks·11/26 06:06
Canaccord Genuity Remains a Buy on Mesoblast Limited (MEOBF)
Dow Jones·11/25 21:17
*Mesoblast Price Target Raised 10% to A$3.30/Share by Jefferies
Dow Jones·11/25 21:16
*Mesoblast Upgraded to Buy from Hold by Jefferies
Benzinga·11/25 15:41
This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
TipRanks·11/25 14:58
Mesoblast Achieves FDA Approval for Ryoncil®
Dow Jones·11/25 13:48
Mesoblast Raised to Buy From Hold by Jefferies
Benzinga·11/25 13:39
Jefferies Upgrades Mesoblast to Buy
TipRanks·11/25 11:25
Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
TipRanks·11/25 10:35
Mesoblast upgraded to Buy from Hold at Jefferies
NASDAQ·11/25 08:31
Mesoblast Sees Continued Ryoncil Revenue Growth For Q4 2025
Same Industry
Name/Symbol
Change%
Price